Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2011 Jul 14;20(1):186–191. doi: 10.1038/oby.2011.210

Table 2. Characteristics of the Health Professionals Follow-Up study population stratified by clinically relevant BMI categories.

Data are reported as mean ± standard deviation or percents (%).

VARIABLE BMI<24.9 BMI 25.0-29.9 BMI≥30.0 P
N 171 191 56 -

Age (years) 66.4 ± 7.5 65.9 ± 7.4 63.9 ± 7.5 0.05
Race (%white) 96.4 99.4 100 0.08
BMI (kg/m2) 22.9 ± 1.4 26.9 ± 1.3 32.6 ± 2.1 <0.001
25(OH)D (ng/mL) 29.6 ± 11.1 28.1 ± 8.8 27.4 ± 8.2 0.08
Adiponectin (μg/mL) 11.4 ± 9.8 9.5 ± 7.3 7.9 ± 5.2 0.002
Systolic Blood Pressure (mmHg) 128 ± 13 132 ± 14 135± 13 <0.001
Diastolic Blood Pressure (mmHg) 82 ± 10 85 ± 9 88 ± 7 <0.001
Dietary Sodium Intake (mg/day) 2049 ± 486 2057 ± 449 2116 ± 604 0.07
Dietary Potassium Intake (mg/day) 3553 ± 637 3468 ± 545 3428 ± 632 0.12
Dietary Calcium Intake (mg/day) 937± 383 912 ± 346 938 ± 396 0.81
Alcohol intake (grams/day) 12.8 ± 15.3 14.9 ± 19.2 13.9 ± 16.1 0.45
Prudent dietary pattern score 0.08 ± 0.93 0.02 ± 0.94 −0.06 ± 1.32 0.38
Physical activity (METS/week) 46.2 ± 73.1 35.0 ± 32.4 28.7 ± 30.3 0.01
Diabetes Status (%yes) 3.5 4.7 5.4 0.49
Hypertension Status (% yes) 36.3 45.6 51.8 0.02
Use of Any Anti-Hypertensive Drug (%yes) 25.7 36.6 37.5 0.03